OBJECTIVES: To compare inter-alpha inhibitor protein (IaIp) levels in neonates with proven necrotizing enterocolitis (NEC) and neonates with other, nonspecific abdominal disorders. STUDY DESIGN: This was a prospective observational study of neonates in the neonatal intensive care unit. NEC was diagnosed according to Bell's staging criteria. The nNeonates in the control group had a nonspecific abdominal disorder, but no radiographic evidence of NEC and no disease progression. All neonates with radiographically confirmed NEC were included. Plasma IaIp levels were quantitated by enzyme-linked immunosorbent assay. RESULTS: Seventeen neonates had confirmed NEC, and 34 neonates had nonspecific abdominal disorders that improved rapidly. Gestational age, postnatal age, weight, sex, maternal obstetric variables, rupture of membranes, and mode of delivery did not differ between the two groups. Mean IaIp level was significantly lower in the NEC group compared with the control group (137 ± 38 mg/L; 95% confidence interval [CI], 118-157 mg/L vs 258 ± 53 mg/L; 95% CI, 238-277 mg/L; P <.0001). CONCLUSIONS: The finding of significantly lower IaIp levels in neonates with NEC suggests that IaIp might be a useful, sensitive biomarker, allowing initiation of appropriate therapy and reducing antibiotic overuse in neonates with suspected but unproven NEC. Administration of IaIp may significantly reduce the severity of systemic inflammation and associated tissue injury.
OBJECTIVES: To compare inter-alpha inhibitor protein (IaIp) levels in neonates with proven necrotizing enterocolitis (NEC) and neonates with other, nonspecific abdominal disorders. STUDY DESIGN: This was a prospective observational study of neonates in the neonatal intensive care unit. NEC was diagnosed according to Bell's staging criteria. The nNeonates in the control group had a nonspecific abdominal disorder, but no radiographic evidence of NEC and no disease progression. All neonates with radiographically confirmed NEC were included. Plasma IaIp levels were quantitated by enzyme-linked immunosorbent assay. RESULTS: Seventeen neonates had confirmed NEC, and 34 neonates had nonspecific abdominal disorders that improved rapidly. Gestational age, postnatal age, weight, sex, maternal obstetric variables, rupture of membranes, and mode of delivery did not differ between the two groups. Mean IaIp level was significantly lower in the NEC group compared with the control group (137 ± 38 mg/L; 95% confidence interval [CI], 118-157 mg/L vs 258 ± 53 mg/L; 95% CI, 238-277 mg/L; P <.0001). CONCLUSIONS: The finding of significantly lower IaIp levels in neonates with NEC suggests that IaIp might be a useful, sensitive biomarker, allowing initiation of appropriate therapy and reducing antibiotic overuse in neonates with suspected but unproven NEC. Administration of IaIp may significantly reduce the severity of systemic inflammation and associated tissue injury.
Authors: Yong Woon Baek; Sebastian Brokat; James F Padbury; Halit Pinar; Douglas C Hixson; Yow-Pin Lim Journal: J Pediatr Date: 2003-07 Impact factor: 4.406
Authors: Yow-Pin Lim; Kresimir Bendelja; Steven M Opal; Edward Siryaporn; Douglas C Hixson; John E Palardy Journal: J Infect Dis Date: 2003-08-26 Impact factor: 5.226
Authors: Aric F Logsdon; Michelle A Erickson; Xiaodi Chen; Joseph Qiu; Yow-Pin Lim; Barbara S Stonestreet; William A Banks Journal: J Cereb Blood Flow Metab Date: 2019-06-24 Impact factor: 6.200
Authors: Karl G Sylvester; Xuefeng B Ling; Gigi Yuen-Gee Liu; Zachary J Kastenberg; Jun Ji; Zhongkai Hu; Shuaibin Wu; Sihua Peng; Fizan Abdullah; Mary L Brandt; Richard A Ehrenkranz; Mary Catherine Harris; Timothy C Lee; B Joyce Simpson; Corinna Bowers; R Lawrence Moss Journal: J Pediatr Date: 2014-01-14 Impact factor: 4.406
Authors: Karl G Sylvester; Xuefeng B Ling; G Y Liu; Zachary J Kastenberg; Jun Ji; Zhongkai Hu; Sihua Peng; Ken Lau; Fizan Abdullah; Mary L Brandt; Richard A Ehrenkranz; Mary Catherine Harris; Timothy C Lee; Joyce Simpson; Corinna Bowers; R Lawrence Moss Journal: Gut Date: 2013-09-18 Impact factor: 23.059
Authors: Steven W Threlkeld; Cynthia M Gaudet; Molly E La Rue; Ethan Dugas; Courtney A Hill; Yow-Pin Lim; Barbara S Stonestreet Journal: Exp Neurol Date: 2014-07-30 Impact factor: 5.330
Authors: Mariya S Spasova; Xiaodi Chen; Grazyna B Sadowska; Edward R Horton; Yow-Pin Lim; Barbara S Stonestreet Journal: Dev Neurobiol Date: 2016-11-17 Impact factor: 3.964